Press release
Human Immunodeficiency Virus (HIV) Diagnosis Market Analysis 2024-2033 : Forecast Market Size, Top Segments And Largest Region
"The Business Research Company recently released a comprehensive report on the Global Human Immunodeficiency Virus (HIV) Diagnosis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.According to The Business Research Company's, The HIV diagnosis market size has grown rapidly in recent years. It will grow from $3.79 billion in 2023 to $4.2 billion in 2024 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to expansion of voluntary counseling and testing, development of HIV antibody tests, emergence of the HIV/AIDS epidemic, and community-led and peer-led initiatives.
The HIV diagnosis market size is expected to see rapid growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to public health campaigns and awareness initiatives, focus on equity and inclusivity, routine testing in healthcare settings, community-led and peer-led approaches, and expansion of self-testing. Major trends in the forecast period include advancements in testing technologies, focus on targeted testing strategies, community-based testing and outreach, emphasis on equity and inclusivity, and policy and funding priorities.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report
Market Drivers and Trends:
The rising blood donation is expected to propel the growth of the HIV diagnosis market going forward. Blood donation refers to the voluntary act of giving blood through phlebotomy, where a needle is inserted into a vein to collect blood. The rise in blood donation combines advancements in medical technology, community engagement, and improved donor recruitment and retention strategies. With more people donating blood, a larger pool of samples is available for HIV testing. This increased availability of blood samples allows for more comprehensive screening for HIV antibodies or antigens, improving the accuracy and reliability of HIV diagnosis. For instance, NHS Blood and Transplant, a UK-based government agency, increased the number of new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Therefore, rising blood donation is driving the growth of the HIV diagnosis market.
Major companies operating in the HIV diagnosis market are developing chip-based real-time PCR test solutions for HIV to improve accuracy, reduce turnaround time, and enhance accessibility. Chip-based real-time PCR test solutions for HIV are diagnostic tools that utilize microfluidic chips or small integrated circuits to conduct real-time polymerase chain reaction (PCR) tests for detecting HIV. For instance, in August 2022, Molbio Diagnostics, an India-based molecular diagnostics manufacturer, launched the Truenat HIV-1 test, a chip-based real-time PCR test for the quantitative detection and diagnosis of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma. This test is designed to aid in the monitoring of the HIV-1 viral load in patients with HIV-1 infection. The test is based on Taqman chemistry and features high primer sensitivity and specificity. It requires a minimal sample volume of 6 mcL and includes an intelligent chip with lot-specific data to quantify results. The test consists of a chip re-use lock and a reaction port with contamination- and evaporation-resistant design.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp
Major Key Players of the Market:
Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.
Human Immunodeficiency Virus (HIV) Diagnosis Market 2024 Key Insights:
• The HIV diagnosis market size is expected to see rapid growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%.
• Rising Blood Donation On The HIV Diagnosis Market
• Advancing Chip-Based Real-Time PCR For HIV Detection
• North America was the largest region in the HIV diagnosis market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15587&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Immunodeficiency Virus (HIV) Diagnosis Market Analysis 2024-2033 : Forecast Market Size, Top Segments And Largest Region here
News-ID: 3705680 • Views: …
More Releases from The Business Research Company

The Role Of Advanced Driver-Assistance Systems (ADAS) In Autonomous Vehicle Simu …
The Autonomous Vehicle Simulation Solutions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Autonomous Vehicle Simulation Solutions Market Size During the Forecast Period?
In recent times, there's been significant growth in the market size of autonomous vehicle simulation solutions. Forecasted expansion shows…

Autonomous Agents Industry Report 2025-2034: Market Dynamics, Trends, And Foreca …
The Autonomous Agents Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Autonomous Agents Market Size During the Forecast Period?
In the last few years, the market size for autonomous agents has seen an exponential rise. The projection is that its worth will…

Evolving Market Trends In The Automotive Smart Antenna Industry: Transparent Ant …
The Automotive Smart Antenna Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Automotive Smart Antenna Market Size During the Forecast Period?
Over the years, the market size of the automotive smart antenna has witnessed significant growth. This market is projected to expand…

Automotive Prognostics Market Surges In Response To Road Accident Concerns: Key …
The Automotive Prognostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Automotive Prognostics Market Size During the Forecast Period?
In recent times, the automotive prognostics market has witnessed a significant expansion. The market size, which is at $8.32 billion in 2024, is…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…